Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psiguavin for Obesity Treatment
NCT06512818Phase 2Enrolling by invitation
- Sponsor
- Universidad Católica San Antonio de Murcia
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universidad Católica San Antonio de Murcia. Primary endpoints: Percentage of body weight loss at 15 months and Percentage of body fat loss at 15 months. Started Jan 2025; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT06512818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06512818.